GeNeuro S.A.
GNRO.PA · PAR
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | €294 | €289 | €300 | €335 |
| Gross Profit | -€294 | -€289 | -€300 | -€335 |
| % Margin | – | – | – | – |
| R&D Expenses | €12,305 | €9,675 | €4,887 | €4,537 |
| G&A Expenses | €2,971 | €3 | €3 | €3 |
| SG&A Expenses | €3,054 | €3,079 | €2,494 | €3,131 |
| Sales & Mktg Exp. | €83 | €3,075 | €2,491 | €3,128 |
| Other Operating Expenses | -€152 | €13 | -€142 | €38 |
| Operating Expenses | €15,207 | €12,767 | €7,239 | €7,706 |
| Operating Income | -€14,357 | -€13,055 | -€7,539 | -€8,041 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -€951 | -€459 | -€286 | -€1,476 |
| Pre-Tax Income | -€15,309 | -€13,514 | -€7,825 | -€9,516 |
| Tax Expense | -€552 | -€1,314 | -€1,007 | -€554 |
| Net Income | -€14,757 | -€12,200 | -€6,818 | -€8,962 |
| % Margin | – | – | – | – |
| EPS | -0.59 | -0.51 | -0.32 | -0.45 |
| % Growth | -15.7% | -59.4% | 28.9% | – |
| EPS Diluted | -0.59 | -0.51 | -0.32 | -0.45 |
| Weighted Avg Shares Out | 24,843 | 23,898 | 21,280 | 19,969 |
| Weighted Avg Shares Out Dil | 24,843 | 23,898 | 21,280 | 19,969 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €953 | €269 | €41 | €80 |
| Depreciation & Amortization | €40 | €289 | €300 | €335 |
| EBITDA | -€14,318 | -€12,956 | -€7,484 | -€9,101 |
| % Margin | – | – | – | – |